Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

QIAGEN Sciences LLC

United States·US-MF-000014502

Last updated September 18, 2026

About

At QIAGEN, we don’t wait – we make it possible. We roll up our sleeves, think differently and work side by side to make improvements in life possible.

From the manufacturer's own website. Source

Information

Country
United States
Address
19300, Germantown Road, Germantown, United States
Phone
+12406867700
PRRC Contact
Donna Sowers
EUDAMED SRN
US-MF-000014502
FDA FEI Number
—
DUNS Number
—

Catalogue (27)

DeviceModel / ReferenceRegistriesClassStatus
Hybrid Capture System Multi-Specimen Tube Vortexer 2 6000-5022
EUDAMED
Class AActive
Hybrid Capture System Microplate Heater 1 6000-1240U
EUDAMED
Class AActive
QuantiFERON-TB Gold Blood Collection Tubes Dispenser Pack 1
FDA UDI
Class IIIActive
QuantiFERON®-TB Gold Plus 1
FDA UDI
Class IIIActive
QuantiFERON®-TB Gold Plus 1
FDA UDI
Class IIIActive
QuantiFERON®-TB Gold Plus 1
FDA UDI
Class IIIActive
QuantiFERON®-TB Gold Plus 1
FDA UDI
Class IIIActive
QuantiFERON®-TB Gold Plus 1
FDA UDI
Class IIIActive
digene® HC2 CT/GC DNA Test 2
FDA UDI
Class IIActive
QuantiFERON-TB Gold 2 Plate Kit 1
FDA UDI
Class IIIActive
QuantiFERON®-TB Gold Plus 1
FDA UDI
Class IIIActive
QuantiFERON-TB Gold Blood Collection Tubes Dispenser Pack - High Altitude 1
FDA UDI
Class IIIActive
digene® HC2 GC-ID DNA Test 2
FDA UDI
Class IIActive
IGRA Control Set 1
FDA UDI
Class IActive
QuantiFERON-TB Gold Blood Collection Tubes 1
FDA UDI
Class IIIActive
QuantiFERON®-TB Gold Plus 1
FDA UDI
Class IIIActive
QuantiFERON-TB Gold Reference Lab Pack 1
FDA UDI
Class IIIActive
digene® HC2 DNA Collection Device 1
FDA UDI
Class IIActive
hc2 High-Risk HPV DNA Test 1
FDA UDI
Class IIIActive
hc2 High-Risk HPV DNA Test 1
FDA UDI
Class IIIActive
QuantiFERON®-TB Gold Plus 1
FDA UDI
Class IIIActive
hc2 HPV DNA Test 1
FDA UDI
Class IIIActive
digene® Wash Buffer Concentrate 1
FDA UDI
Class IIIActive
QuantiFERON-TB Gold Blood Collection Tubes - High Altitude 1
FDA UDI
Class IIIActive
Rapid Capture System 6000-3101
EUDAMEDFDA UDI
Class AActive
Hybrid Capture System Rotary Shaker 1 6000-2240E
EUDAMED
Class AActive
Dml 3000 5000-00031
EUDAMEDFDA UDI
Class AActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (23)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Mar 12, 2025Z-1504-2025—open, classified

Identified faulty cartridges. If such a faulty cartridge is used for sample testing, false test results could occur.

Jun 3, 2024Z-2353-2024—open, classified

Heater shaker module does not perform heating if the temperature is set below 40C for static incubation steps when running IVD protocol QIAamp DSP DNA Mini Kit (cat. no. 61304), Protocol: Isolation of genomic DNA from Gram-positive bacteria (Script filename: Kt_name_Bacteria (Gram+) or rY'east_Enzymatic Lysis_ V2) which could potentially cause delayed or erroneous results depending on the downstream assay.

Mar 4, 2024Z-1508-2024—open, classified

Insufficient welding leads to the heater cable becoming brittle and present with an error: ERROR 3481 HEATER UNABLE TO REACH TEMPERATURE; the instrument may stop, and the sample being processed will be lost

Apr 28, 2023Z-1683-2023—open, classified

Faulty cartridges in the lot could result in false test results.

Jul 20, 2022Z-1650-2022—open, classified

Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects

Jul 20, 2022Z-1651-2022—open, classified

Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects

Jul 20, 2022Z-1652-2022—open, classified

Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects

Feb 25, 2022Z-0951-2022—open, classified

False positive or false negative G12C (12CYS) mutation result for the KRAS Mutation Status resulting from Flags/Warnings may invalidate the result for one or more individual mutation target of the kit.

Feb 25, 2022Z-0952-2022—open, classified

False positive or false negative G12C (12CYS) mutation result for the KRAS Mutation Status resulting from Flags/Warnings may invalidate the result for one or more individual mutation target of the kit.

Nov 21, 2021Z-1746-2022—open, classified

During the "Load tip racks and enzymes" step of the run set-up, the info screen indicates "minimal volume to be loaded", but the indicated volume is instead the exact volume that should be loaded. Misunderstanding the guidance may lead to over diluted, under diluted, or improperly lysed sample, which in turn could lead to false negative or false positive results.

Nov 8, 2021Z-0455-2022—terminated

The firm identified sixteen (16) faulty cartridges in LOT 210209, which contain incorrect primer-probe mixes in the reaction chambers. If an affected cartridge is used, false-negative, false-positive, or both false-negative and false-positive results could occur.

Jan 15, 2021Z-0941-2021—terminated

QIAGEN has become aware of the potential for false positive results to occur with some patient samples.

Dec 11, 2020Z-0937-2021—terminated

Kit may generate false Q546R mutation positive results caused by nonspecific molecular interactions within the Q546R higher than previously observed and described within the Instructions For Use.

Jul 15, 2020Z-2938-2020—terminated

There is an increased rate of potential false positive results for the Influenza A (no subtype) target, which may lead to 1) inappropriate antiviral use, 2) erroneous or delayed differential diagnosis and missing of an alternative diagnosis.

Apr 8, 2020Z-2290-2020—terminated

There is a risk for a false mutation positive result in rare cases resulting from a fluorescence artefact. In these rare cases, the controls pass correctly, while a fluorescence artefact in the mutation assay causes an incorrect valid mutation positive result.

Feb 21, 2020Z-1636-2020—terminated

An image on the associated polybag contains an incorrect rinse time of 30 (thirty seconds). The correct rinse time is 1 (one) minute.

Jan 28, 2020Z-1476-2020—terminated

When using the Rotor-Gene Q with Software version 2.3.4 completing a LIMs export, the .csv file reports the calculated concentration result value as a logarithmic value, and could lead to a false negative result, which could lead to serious medical consequences such as the suspension or non-initiation of treatment

Jul 2, 2019Z-2319-2019—open, classified

QIAsymphony software version 5.0.3 - Software issue incorreclty assigns the 2D bar code eluate ID to the sample within the results file. If 2D bar code eluate IDs are not checked against the sample ID prior to downstream application the incorrect tube may be selected and it could have the potential to lead to delayed results or incorrect patient reporting

Jun 5, 2019Z-2088-2019—terminated

Kit lots contain a small percentage of damaged Filter-Tips that are leaking when being used with the QIAsymphony SP/AS Instruments (REF 9001297 and 9001301)

May 6, 2019Z-1891-2019—terminated

The deparaffinization solution contains a contaminant, which leads to reduced lysis efficiency of the affected lot, resulting in significantly reduced yields and less sensitive downstream applications.

Jul 23, 2018Z-0383-2019—terminated

An issue with the power branching printed circuit board (PCB) on the instrument that has the potential to trigger a heater malfunction was discovered. If this failure were to occur, nucleic acid extractions could be compromised and extractions need to be repeated. This could cause a delay in obtaining results from downstream applications.

May 18, 2018Z-2577-2018—terminated

Potential for control line not appearing on the test strip

Feb 2, 2016Z-1230-2016—terminated

Potential for obtaining a false positive result due to the possibility of endotoxin presence.